Caitong International Asset Management Co., LTD Castle Biosciences Inc Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 156 shares of CSTL stock, worth $2,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156Holding current value
$2,570% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
193Shares Held
26.4MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$50.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$33.7 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$24.2 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$20.9 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$19.8 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $433M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...